Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Herbalife Reaffirms Guidance for Q3, Full-Year

Herbalife Reaffirms Guidance for Q3, Full-Year

MT newswireMT newswire2026/08/31 14:31
10:31 AM EDT, 08/31/2026 (MT Newswires) -- Herbalife (HLF) said Monday that it is reaffirming its guidance for Q3 and the full-year, previously provided on Aug. 5. The company said it continues to expect Q3 net sales growth of 0.5% to 4.5% year-over-year along with adjusted earnings before interest, taxes, depreciation, and amortization of $160 million to $180 million. Three analysts polled by FactSet expect net sales of $1.31 billion and one analyst expects adjusted EBITDA of $165 million. For the full-year, the company continues to expect net sales growth of 2.5% to 5.5%, along with adjusted EBITDA of $670 million to $690 million. Three analysts expect 2026 net sales of $5.26 billion and one analyst expects adjusted EBITDA of $674 million. Shares of the company were down more than 12% in early Monday trading. Price: 10.84, Change: -1.59, Percent Change: -12.79
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%

Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.

智通财经2026/09/21 23:36

700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released

Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.

智通财经2026/09/21 23:31